About this trial
Introduction Parkinson's disease (PD) limits mobility by worsening gait/walking and increasing fall risk. Falls lead to injuries and reduce confidence in performing everyday tasks. That lowers a person's ability to participate in community activities such as going to the shops or visiting friends, which reduces their quality of life. Development of interventions for gait impairments and falls is a research priority for Parkinson's UK.
Understanding gait Traditionally, one approach a physiotherapist may use to try and improve/retrain a person's gait is with an electronic metronome which is a device that "beeps" nearly every second. The physiotherapist sets the metronome beeping, and the person tries to step to each beep. However, success depends on the physio's expertise/experience. Regardless, beeping sounds are described as boring.
Smartphone app An app may be the solution. Smartphones have many sensors, meaning they can accurately measure gait but also deliver retraining via music. That is possible by the creation of an "app" that can be downloaded and installed on anyone's smartphone.
Research proposal The investigators have developed and validated an app (CuePD) that uses music for gait retraining, to make it more enjoyable by having people listen to their preferred music. The aim for this study is to get people with PD (PwPD) using CuePD in their home and when out walking for 12-weeks to determine: (i) how PwPD use and value CuePD and (ii) CuePD's ability to improve gait to reduce fall risk.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Able to walk unaided.
Diagnosis of idiopathic Parkinson's.
Score ≥21/30 on Montreal Cognitive Assessment (MoCA) which is used to classify non-demented Parkinson's (Parkinson's dementia is <21/30).
Uses a smartphone.
Disqualifiers
Non-English speakers
Use of any mobility aids e.g., walking stick
History of stroke, traumatic brain injury or other neurological disorders (other than Parkinson's)
Unable to comply with the testing protocol or currently participating in another interfering research project.
Trial design
Parallel
Treatments tested in this trial
CuePD
DeviceUse of the CuePD smartphone app to listen to musical cues.
Control material
Other interventionReading of leaflet and information booklet
Treatment groups
Trial outcomes
Primary outcomes
Gait speed
Assessed by the CuePD app on the person's own smartphone (attached to the lower back by a belt attachment) while walking for 1-min. CuePD uses validated gait algorithms (Wall et al https://doi.org/10.1016/j.eswa.2025.128090).
Stride length
Assessed by the CuePD app on the person's own smartphone (attached to the lower back by a belt attachment) while walking for 1-min. CuePD uses validated gait algorithms (Wall et al https://doi.org/10.1016/j.eswa.2025.128090).
Step time coefficient of variation
Assessed by the CuePD app on the person's own smartphone (attached to the lower back by a belt attachment) while walking for 1-min. CuePD uses validated gait algorithms (Wall et al https://doi.org/10.1016/j.eswa.2025.128090).
Secondary outcomes
Fall frequency
Use of a self-report falls diary to make a record of any fall or near fall event. The diary will consist of a calendar for participants to make a good record of the day and time as well as space to try and capture context of the event.
Cost effectiveness
Client Services Receipt Inventory (CSRI) questionnaire. CSRI collects data on service use and has been used in many evaluations of health and social care interventions over the past 30-years. It records the interviewee's use of health and social care services, accommodation and living situation, income, employment and benefits. Service use data are combined with appropriate unit costs to generate total care costs/participant.
Cost-utility analysis
The EQ-5D is a brief scale to measure health related quality of life (HRQoL) across 5-dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. For each domain participants are asked to rate their current health using a five-point scale, describing the extent to which they can perform activities ("No problems" to "Unable to perform"). It also includes a visual analogue scale on which participants mark their current status between 0 (worst health they can imagine) and 100 (best health they can imagine). Quality Adjusted Life Years (QALYs) will be derived from the EQ-5D scores for the cost-utility analysis.
Perceptions
Participants (control and intervention) will be invited to focus groups to expand findings. Consenting views of (maximum) 10 CuePD intervention and 10 control participants will be sought in a series of focus groups. Focus groups will be separate to the main study and undertaken after the 12-week outcome assessments. Questions (e.g., did a care encourage use?) will explore participant experiences and factors influencing adherence. Focus groups will be voice recorded and transcripts will be analysed to identify themes and connections. A thematic analysis will analyse the focus group data as it is a flexible method that allows themes to emerge from the data and has previously been used by the team to analyse data following discussions relating to the technology to assess gait and reduce fall risk within PD. The thematic approach can produce insights via the participants voice to help answer the research questions.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Northumbria University
Lead sponsor
North Tyneside General Hospital
Collaborator
Northumbria Healthcare NHS Foundation Trust
Collaborator
Northumberland, Tyne and Wear NHS Foundation Trust
Collaborator
This trial is not recruiting at the moment. You can still explore other options: